25th and 26th of June 2025, Schloss Birlinghoven, Fraunhofer IZB Campus, Sankt Augustin
https://www.scai.fraunhofer.de/en/contact-fraunhofer-scai/travel-directions-birlinghoven.html
Join us for the Symposium: Towards Earlier Diagnosis of Alzheimer’s Disease, where leading experts will gather to discuss groundbreaking research and innovative strategies aimed at improving the early diagnosis of Alzheimer’s disease. This event is a key opportunity to explore the latest advancements stemming from the ADIS project, which focuses on immune profiling of cytotoxic lymphocytes and the recording of sleep disturbances to identify Alzheimer’s disease at its earliest stages.
Alzheimer’s disease is the most prevalent neurodegenerative disorder, affecting millions of individuals worldwide. Early diagnosis is crucial for effective intervention, yet current diagnostic methods often lack the necessary sensitivity and accessibility. This symposium provides a platform for researchers, clinicians, and industry professionals to share their findings, discuss best practices, and collaborate on future directions in Alzheimer’s research, ultimately aiming to enhance early detection capabilities.
The ADIS project, funded by the EU Joint Programme Neurodegenerative Disease Research (JPND), unites a diverse consortium of partners from Germany, Spain, Israel, Luxembourg and Hungary. By leveraging advanced technologies and interdisciplinary approaches, the project seeks to uncover new blood-based and sleep-based biomarkers that can detect Alzheimer’s disease in its prodromal stages. This symposium will showcase the project’s key findings, encourage dialogue among stakeholders, and pave the way for the implementation of innovative diagnostic tools in clinical practice.
Join us as we work towards a future of earlier diagnosis and improved outcomes for individuals affected by Alzheimer’s disease.